The Anticonvulsants market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 3.60% in the forecast period of 2021 to 2028 and expected to reach USD 21.5 billion by 2028.

Anticonvulsants are the pharmaceutical agents which are used for the treatment of epileptic seizures. They are also known as anti-epileptic drugs and anti-seizure drugs. These drugs are either classified as first generation agents and second generation agents. They act as a mood stabilizers and also used in the treatment of neuropathic pain.

Read More : https://www.databridgemarketresearch.com/reports/global-anticonvuls...

Rise in the prevalence of epilepsy worldwide is the major factor responsible for the growth of market. Increasing approvals for anticonvulsant drugs from Food and drug administration (FDA) will enhance the anticonvulsants market. Also, growing use of anticonvulsant market to treat pain during migraine and fibromyalgia, growing healthcare expenditure and rising preferences for generic products are the factors that will expand the anticonvulsants market. Rise in the research and development activities and increase in the number of product approvals from regulatory bodies will provide beneficial opportunities for the anticonvulsants market in the forecast period of 2021-2028.

However, high cost of drugs, availability of alternative options for pain management and side effects associated with the anticonvulsant drugs such as stomach pain and tenderness, ulcers in mouth, sores, excessive bleeding in wounds, fever, and unusual infections are the factors that will hinder the market growth and will further challenge the anticonvulsants market in the forecast period mentioned above.

Global Anticonvulsants Market Scope and Market Size
The anticonvulsants market is segmented on the basis of drug class, dosage, route of administration, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of drug class, the anticonvulsants market is segmented into pyrimidinediones, benzodiazepines, fructose derivatives, aromatic allylic alcohols, valproylamides, carboxamides, bromides, carbamates, aldehydes, sulfonamides, pyrrolidines, triazines, fatty acids, propionates, oxazolidinediones, hydantoins, barbiturates and others.
On the basis of dosage, the anticonvulsants market is segmented into tablet, capsule, liquid, rectal gel, cream and others.
On the basis of route of administration, the anticonvulsants market is segmented into topical, eternal and parenteral.
On the basis of application, the anticonvulsants market is segmented into migraine, epilepsy, neuropathic pain, anxiety, fibromyalgia, bipolar disorder and borderline personality disorder.
On the basis of end-users, the anticonvulsants market is segmented into clinic, hospital and others.
The major players covered in the anticonvulsants market report are Novartis AG, Sanofi, Pfizer Inc., Johnson & Johnson Private Limited, Abbott, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Sunovion Pharmaceuticals Inc., GW Pharmaceuticals plc., AstraZeneca, GlaxoSmithKline plc, H. Lundbeck A/S, Takeda Pharmaceutical Company Limited., Sumitomo Dainippon Pharma Co., Ltd., Biocon, Merck KGaA, Cadila Pharmaceuticals, Eisai Co., Ltd., Cipla Inc., Glenmark Pharmaceuticals Limited, Mankind Pharma, Novo Nordisk A/S, Otsuka America Pharmaceutical, Inc, and WOCKHARDT, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

https://www.databridgemarketresearch.com/reports/global-hydantoin-a...

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- [email protected]